sFRP2 also triggers a multi‐step signaling cascade in melanoma cells, leading to a reduction in β‐catenin and MITF, and consequently, the loss of a key redox effector, apurinic/apyrimidinic endonuclease 1 (APE1). The gene discussed is SFRP2; the disease is melanoma.